🔗 Visit the ClinicalTrials.gov page for NCT01698307
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Infliximab, azathioprine, or combination therapy for Crohn's disease. | N Engl J Med | 2010 | 12.35 |
| 2 | Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. | Lancet | 2008 | 10.47 |
| 3 | Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. | Clin Gastroenterol Hepatol | 2006 | 4.18 |
| 4 | Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study. | Gastroenterology | 2008 | 1.78 |
| 5 | Adalimumab induces deep remission in patients with Crohn's disease. | Clin Gastroenterol Hepatol | 2013 | 1.42 |
| 6 | Reversibility of Stricturing Crohn's Disease-Fact or Fiction? | Inflamm Bowel Dis | 2016 | 0.77 |